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Introduction
Chronic obstructive pulmonary disease (COPD) is a progres-
sive lung disease. It is a frequent cause of hospitalizations, 
visits to the general practitioner, extensive use of medication 
and reduced quality of life (QoL). COPD is characterized by 
a chronic inflammatory condition leading to progressive air-
way obstruction and gradually reduced lung function. The 
symptoms are breathlessness, coughing, wheezing, sputum, 
frequent respiratory tract infections and exacerbations.1,2 
The symptoms progress slowly and are blurred; therefore, 
Development of non-invasive ventilation 
treatment practice for patients with  
chronic obstructive pulmonary 
disease:Results from a participatory  
research project 
Helle M Christensen1,2, Ingrid L Titlestad1,2 and Lotte Huniche3
Abstract
Objectives: Non-invasive ventilation treatment for patients with acute exacerbation of chronic obstructive pulmonary 
disease is well documented. Communication with patients during treatment is inhibited because of the mask, the noise from 
the machine and patient distress. Assessing life expectancy and identifying end-stage chronic obstructive pulmonary disease 
posed difficulties and caused doubts concerning initiation and continuation of non-invasive ventilation as life-sustaining 
treatment. Health professionals expressed a need for knowledge of patients’ perspectives and attitude towards non-invasive 
ventilation.
Methods: The study adheres to principles of Critical psychological practice research. Data on patients’ and health 
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treatment practice at the department, drawing on research literature, results from observations and patients’ interviews.
Results: Interviews revealed that 15 patients evaluated treatment with non-invasive ventilation positively, although 13 had 
experienced fear and 14 discomfort during treatment. The co-researcher group described health professionals’ perspectives 
and analysed treatment practice based on data from patients’ perspectives developing new management strategies in clinical 
practice with non-invasive ventilation.
Conclusion: The participatory approach enabled continuous and complementary development of knowledge and treatment 
practice. The investigation of patient perspectives was particularly productive in qualifying cooperation among health 
professionals. The study resulted in preparing, and implementing, new clinical strategies.
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patients are often diagnosed in the later stages of the dis-
ease.3 COPD is an important cause of morbidity worldwide 
and ranks as the fourth most common cause of mortality.3 
Smoking is the most important factor causing COPD. At 
least 50% of smokers contract the disease.4 After an acute 
exacerbation of COPD, the prospect of returning to a prior 
level of function is small.3,5
Non-invasive ventilation (NIV) for patients with acute 
exacerbation of COPD and with respiratory failure is a well-
documented treatment used internationally.6,7 Standard treat-
ment for patients with acute exacerbation of COPD also 
includes medical treatment with bronchodilators, corticoids, 
optional antibiotics and oxygen.8,9 The Department of 
Respiratory Medicine in this study gives NIV in accordance 
with British Thoracic Society guidelines, based on evidence 
group A: patients who benefit from NIV should receive as 
much NIV as possible in the first 24 h. On the second and 
third day at least 16 and 12 h, respectively, should be given.10 
A randomized multicenter study shows that supplementation 
with NIV decreased mortality from 22% to 9%.6 The patient’s 
ability to tolerate the mask, the recommended hours and syn-
chronizing breathing with the NIV machine play a key role 
in the result of NIV treatment.10 Treatment with NIV is 
administered by a mask that fits tightly around the patient’s 
nose and mouth. Communication during treatment with NIV 
is difficult because of the mask and the noise of the machine. 
It is also made difficult by the patient’s acute condition, 
which is often characterized by having fluctuating levels of 
consciousness, fear and a feeling of suffocation.11,12
The presence of acute or chronic respiratory failure and 
treatment with NIV is often evaluated as a predictor of end stage 
of COPD.13,14 Exactly when the patient with COPD is at the end 
stage of the disease is difficult to determine. There are no exact 
biomarkers except low lung function and co-morbidity.15–17 
Therefore, the health professional has to consider the individu-
al’s physical and mental condition in deciding whether to start 
treatment with NIV. Difficulties in communicating with patients 
and recurring acute exacerbations of COPD complicate this 
decision further. Health professionals often experience resist-
ance from patients while fitting the mask and consider it an ethi-
cal challenge to start treatment while patients struggle against 
their efforts. The health professionals involved in NIV treat-
ment had varying approaches to treatment during end-stage 
COPD, for example, to always treat the patient regardless of 
stage of the disease, or withhold treatment in a terminal stage. 
The health professionals agreed that knowledge of patients’ per-
spectives on treatment was necessary.
Searches in PubMed, CINAHL, PsycINFO and Cochrane 
reveal few studies on patient experiences and attitudes 
towards treatment with NIV. Studies by Torheim and 
Gjengedal,11 Sørensen et al.,18 Beckert et al.19 and Smith 
et al.20 present patients’ experience with NIV, with a focus on 
describing the approaches which patients use to adapt to NIV 
such as feeling of regaining control and trusting skilled help 
from health professionals. Smith et al.20 conclude that more 
research is needed on patients’ daily lives with COPD versus 
their attitudes to acute exacerbation of COPD, which can 
give clinicians a better understanding of the patient’s per-
spective and thereby build up and qualify management strat-
egies for NIV treatment. The studies don’t look further into 
the attitude towards receiving NIV considering how they 
relates to, and live their lives with a chronical illness COPD 
where hospitalization due to acute exacerbation of COPD is 
a progress of their illness. Former studies on NIV treatment 
of patients with COPD conclude that there is need for more 
investigations about the patients’ and their relatives’ experi-
ence and attitudes towards NIV treatment.21–23
Aim
1. To investigate user perspectives on health care prac-
tice in the hospital concerning NIV treatment. Users 
defined as patients, relatives and health professionals.
2. To understand how patients with COPD and health 
professionals experience and evaluate treatment 
with NIV.
3. To develop new management strategies for NIV 
treatment of patients with COPD based on patients’, 
relatives’ and health professionals’ perspectives on 
treatment.
Method
The theoretical framework used in the study was critical psy-
chological practice research. Critical psychology is built on 
historical dialectical materialism24 (Table 1). It focuses the 
investigation of first-person perspectives on the conduct of 
everyday life and work practices. Its purpose is to understand 
how individuals participate in social contexts24–26 (Table 1). 
Critical psychological practice research was chosen because 
our study intends to clarify first-person perspectives on liv-
ing with COPD and on health professionals’ clinical prac-
tice. Simultaneously, the method used investigates and 
develop practice by involving practitioners in the research 
process and continuously feeding results back into practice. 
The purpose is to develop understandings of why and how 
individuals act, think and feel about NIV from various posi-
tions as patients, relatives or professionals. The advantage of 
this approach was that it revealed how patients and their rela-
tives experienced illness and treatment in the broader context 
of their everyday lives. This knowledge could in turn be 
related to difficulties experienced by health professionals 
during their efforts to treat and care for these patients in a 
clinical context.27–31 Critical psychological practice research 
aims to develop theory as well as practice in a joint process.
Design
A co-researcher group (Table 2) was set up comprising the 
principal researcher (first author) and six selected clinical 
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co-researchers from a Department of Respiratory 
Medicine in Denmark. The co-research group was selected 
to represent all health professional groups involved in 
treatment with NIV. We strove to recruit health profes-
sionals with dissimilar bases of experience and in differ-
ent age groups. The co-research group convened eight 
times over the course of 12 months. All meetings lasted 
from 45 to 90 min and were audio-recorded. The principal 
researcher contributed with perspectives drawn from par-
ticipant observation of treatment practices at the depart-
ment and from semi-structured interviews with patients 
and relatives following hospitalization and treatment with 
NIV. The co-researcher group described and analysed 
practice with NIV, looking for possibilities and constraints 
in the clinical practice, based on the analysis of the 
patients’ perspectives of treatment. This design was cho-
sen to identify possibilities and constraint in practice, and 
at the same time develop, explore and implement new 
knowledge into the clinical practice with NIV. Participant 
observation was carried out by the principal researcher 
to obtain an understanding of the daily routines 
and practices of NIV treatment at the department.20,21,31 
Semi-structured interviews were carried out to capture 
perspectives of patients and relatives.
Patient and relatives recruitment
Patients’ perspective in this study was based on 20 inform-
ants: 16 patients with severe COPD treated with NIV at 
least once during the last 2 years and 4 relatives (Table 3). 
This study looks further into the attitude towards receiving 
NIV considering how they relates to, and live their lives 
with a chronical illness COPD where hospitalization due 
to acute exacerbation of COPD is a progress of their ill-
ness. It was therefore important to interview the patients 
after some recovering from the acute exacerbation of 
COPD. The informants were selected from medical records 
in the Department of Respiratory Medicine. Recruitment 
was deliberately constructed to include men and women, 
single and married and in different ages. Inclusion criteria 
for the patients were (1) verified COPD, (2) hospitaliza-
tion and treatment with NIV within the previous 2 years 
because of acute exacerbation of COPD or pneumonia and 
(3) not hospitalized at the time of the interview and in a 
Table 1. Definitions of contexts in critical psychology.
Concepts Specification
Critical psychology A psychological theory, also termed the science of the subject, which conceptualizes subjectivity as 
constituted in the historical development of humanity, society and environment. The basic theoretical 
framework was published in ‘Foundations of Psychology’ by Klaus Holzkamp in 1985.
Societal context The material, structural and cultural framework in which subjects unfold their lives, that is, individuals 
live under societal conditions while also maintaining and changing them.
Conditions, meanings and 
reasons
Objective conditions, their subjective meanings and personal reasons for acting in specific ways are 
fundamentally interrelated and must be studied in unison, rather than as isolated units with external 
connections.
First-person perspectives Knowledge of subjective meaning and personal reasons is formed from first-person perspectives to 
understand how conditions produce possibilities and constraints in people’s lives.
Subjects conduct their everyday lives by constantly producing and reproducing routines as well as 
flexible responses to daily challenges.
Conduct of everyday life Subjects conduct their lives in and across contexts throughout their life trajectories.
Personal ability The extent to which subjects are able to assume and act with possibilities and constraints in their 
everyday lives.
Participation Subjects are conceived as fundamentally societal and as participants in and across social contexts with 
other subjects.
Source: Smith et al.,20 Perrin et al.21 and Smith et al.22
Table 2. Participants in the co-researcher group.
Participants Professional education Experience Respiratory medicine
1. Principal researcher (first author) PhD student 10 years
2. Health care professional Nurse 2 years
3. Health care professional Nurse 5 years
4. Health care professional Nurse Over 10 years
5. Health care professional Health care worker Over 10 years
6. Health care professional Physician Less than 1 year
7. Health care professional Physician, assistant professor Over 10 years
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stable period. Exclusion criteria were (1) other imminently 
life-threatening diseases than COPD, for example, lung 
cancer; (2) drug or alcohol abuse; and (3) not being able to 
understand study information and signed consent. The ini-
tial 12 informants all said the same in the interviews; all 
pointed out, in different ways, that they would want treat-
ment with NIV in the future if necessary for a chance to 
survive an exacerbation of COPD or pneumonia. To be 
certain, this was not just a coincidence; the co-researcher 
group sought contact with patients with COPD, who had 
declined treatment with NIV during hospitalization in 
2010 and 2011. Five living individuals were found, one did 
not respond to contact and four were interviewed.
All patients were asked for permission to interview one of 
their relatives, four accepted and their relatives signed an 
informed consent form before interviews.
Data generation process
The Department of Respiratory Medicine agreed to host the 
research project and to assist in recruiting patients and health 
professionals. A letter was sent to the informants containing 
written information on the study aims, design and a consent 
form. Informants were then contacted by telephone. The 
principal researcher, who had previous experience with 
interviews, carried out a face-to-face semi-structured inter-
view with each informant at a location of their choice. All 
interviews took place in the informant’s home. The interview 
was partially participant-led. The reason was to enable the 
informants to tell their story and focus on their experience 
and thoughts about their illness and treatment with NIV. An 
interview guide was designed to aid in understanding how 
patients with COPD experienced treatment with NIV. In 
addition, it helped determine their understanding of the treat-
ment and to establish whether they would consider receiving 
the treatment again. The interview questions included four 
main issues: (1) experience of NIV treatment, (2) the mean-
ing of NIV in everyday life with COPD, (3) main concerns 
about NIV and (4) the impact of living with COPD and their 
expectations to hospital treatment. The interviews lasted 
from 45 to 90 min and were audio-recorded. Each informant 
received a contact telephone number in case there were ques-
tions following the interview. None of the informants made 
contact after the interviews.
Data analysis
The thematic analyses were inspired by Kvale and 
Brinkmann32 and analysed with a critical psychological 
approach. Attention was paid to the informant’s conditions, 
what they meant to them and how they argued about their 
conduct of everyday life and choices regarding COPD and 
NIV.22–24,27 All interviews were transcribed and read several 
times by the principal researcher to identify meaningful 
units in and across the interviews. The analysis was carried 
out with attention to the patients’ understanding and experi-
ence of constraints and possibilities relating to NIV treat-
ment. In addition, the analysis were carried out with a focus 
on the informant’s conduct of an everyday life with COPD, 
patients’ experience of options for actions and the meaning 
of NIV in the patient’s life trajectories. A further analysis of 
the main themes from the interviews was carried out in the 
co-researcher group in light of their clinical experiences 
and understandings, to develop practices related to NIV 
based on patient perspectives on treatment. An example of 
the process on how thematic analysis resulted in develop-
ment of management strategies is exemplified in Table 4. In 
that way, analysis was ongoing during the interviews, 
which allowed specific themes to be further explored in 
later interviews.
Ethical considerations
The study is approved by the Danish Data Protection Agency 
(J.nr. 2011-41-6218) and conducted in conformity with the 
Helsinki declaration. All the informants’ names in this article 
are pseudonyms to ensure anonymity.
Findings
Four main themes emerged through the analysis: understand-
ing resistance towards treatment, physical discomfort or 
relief, coping with anxiety and future treatment with NIV. 
All these themes interact with one another but are presented 
separately in the following presentation.
Understanding resistance towards treatment
Data from health professionals describing their experiences 
from the clinical practice with NIV showed different under-
standings of the experience of the patient’s resistance to the 
treatment: when placing the NIV mask over patient’s mouth 
and nose at the beginning of the NIV treatment, health 
professionals often experienced patient resistance. 
Communication during treatment was experienced as 
difficult due to the tight fit of the mask and the acute 
Table 3. Characteristics of informants.
Characteristics  
Number of patients/relatives 16/4
Sex of patients (male/female) 6/10
Sex of relatives (male/female) 2/2
Married/single 10/10
Using oxygen at home 8
NIV (once/more than once) 10/6
Age, mean/median (range) 69/70 (47–86) years
Last FEV1 (mean/median) 24/20.5%
NIV: non-invasive ventilation; FEV1: Forced Expired Volume in the first second.
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 a
re
n’
t 
do
in
g 
w
el
l. 
W
he
th
er
 t
ha
t 
is
 w
ha
t 
m
ak
es
 it
, I
 c
an
no
t 
gi
ve
 y
ou
 a
n 
ex
pl
an
at
io
n.
 I 
do
 n
ot
 k
no
w
 w
hy
 it
 s
ho
ul
d 
be
 s
o 
tig
ht
.
P1
1:
 I 
ha
d 
to
 g
o 
on
, a
nd
 I 
ha
d 
to
 b
ri
ng
 t
he
 n
um
be
r 
up
 a
nd
 I 
sa
id
, 
I s
im
pl
y 
ca
nn
ot
 b
re
at
he
 in
 it
. I
 fe
lt 
th
at
 it
 w
as
 ju
st
 a
s 
if 
on
e 
w
ou
ld
 
st
ra
ng
le
 y
ou
.
H
ea
lth
 p
ro
fe
ss
io
na
ls
 h
ol
d 
th
e 
vi
ew
 t
ha
t 
m
os
t 
pa
tie
nt
s 
ex
pe
ri
en
ce
d 
tr
ea
tm
en
t 
as
 u
nc
om
fo
rt
ab
le
 
du
e 
to
 t
he
 t
ig
ht
ne
ss
 o
f t
he
 m
as
k.
 T
he
y 
fo
un
d 
th
at
 a
 fe
w
 p
at
ie
nt
s 
ex
pe
ri
en
ce
d 
th
e 
tr
ea
tm
en
t 
as
 a
 r
el
ie
f d
ue
 t
o 
th
e 
br
ea
th
in
g 
as
si
st
an
ce
 a
nd
 
re
du
ci
ng
 fe
el
in
g 
of
 b
ei
ng
 s
tr
an
gl
ed
. N
ur
si
ng
 
ca
re
 w
as
 e
xp
re
ss
ed
 a
s 
be
in
g 
im
po
rt
an
t 
in
 t
he
 
be
gi
nn
in
g 
ph
as
e.
 B
ei
ng
 e
xp
er
ie
nc
ed
 in
 a
dj
us
tin
g 
th
e 
m
as
k 
an
d 
N
IV
 m
ac
hi
ne
 w
as
 c
on
si
de
re
d 
an
 
im
po
rt
an
t 
fa
ct
or
 in
 h
el
pi
ng
 t
he
 p
at
ie
nt
 t
o 
co
pe
:
C
: I
 w
as
 t
hi
nk
in
g,
 t
ho
se
 s
ta
te
m
en
ts
 m
ay
 e
as
e 
th
e 
pr
oc
es
s 
fo
r 
th
e 
pe
op
le
 w
ho
 t
hi
nk
 ‘n
ow
 
I h
av
e 
to
 p
ut
 t
he
 m
as
k 
on
’ w
he
n 
th
er
e 
ar
e 
st
at
em
en
ts
 fr
om
 t
he
 p
at
ie
nt
s,
 t
ha
t 
sa
y 
ev
en
 
th
ou
gh
 I 
re
si
st
, I
 s
til
l a
ct
ua
lly
 w
an
t 
it 
(N
IV
).
In
cr
ea
se
d 
fo
cu
s 
on
 p
hy
si
ca
l p
re
se
nc
e 
as
 
w
el
l a
s 
gu
id
in
g 
th
e 
pa
tie
nt
 t
o 
co
op
er
at
e 
w
ith
 t
he
 N
IV
 m
as
k 
in
 t
he
 in
iti
at
in
g 
ph
as
e.
T
o 
he
lp
 t
he
 p
at
ie
nt
 in
 c
op
in
g 
w
ith
 t
he
 
m
as
k,
 in
tr
od
uc
e 
th
e 
po
ss
ib
ili
ty
 o
f b
ei
ng
 
tr
ea
te
d 
w
ith
 N
IV
 a
t 
an
 e
ar
lie
r 
st
ag
e 
of
 t
he
 
di
se
as
e 
an
d 
ex
pl
ai
n 
w
hy
 t
he
 t
re
at
m
en
t 
is
 
im
po
rt
an
t.
Fo
cu
s 
on
 s
pe
ci
al
 t
ra
in
in
g 
of
 n
ew
 s
ta
ff,
 a
nd
 
up
da
tin
g 
ol
d 
st
af
f w
ith
 t
he
 n
ew
 in
si
gh
ts
 
du
ri
ng
 a
 w
or
ks
ho
p.
(C
on
tin
ue
d)
6 SAGE Open Medicine
Pa
tie
nt
s’
 a
nd
 r
el
at
iv
es
’ p
er
sp
ec
tiv
es
H
ea
lth
 p
ro
fe
ss
io
na
ls
’ p
er
sp
ec
tiv
es
 a
nd
 a
na
ly
si
ng
 
us
er
 p
er
sp
ec
tiv
e 
on
 t
re
at
m
en
t 
w
ith
 N
IV
A
ct
io
n 
an
d 
at
tit
ud
e 
st
ra
te
gi
es
 d
ev
el
op
ed
Co
pi
ng
 w
ith
 a
nx
ie
ty
A
ll 
pa
tie
nt
s 
de
sc
ri
be
d 
an
xi
et
y 
du
ri
ng
 t
he
 t
re
at
m
en
t:
P2
: Y
es
, b
ut
 I 
w
as
 a
fr
ai
d.
 I 
si
m
pl
y 
co
ul
d 
no
t 
…
 A
ll 
th
e 
ne
rv
es
 w
er
e 
si
m
pl
y 
go
ne
. T
he
re
 w
as
 n
ot
hi
ng
 le
ft
. A
nd
 t
he
n 
fe
ar
 c
om
es
 in
to
 it
 
an
d 
m
ak
es
 it
 m
uc
h 
w
or
se
. T
he
n 
yo
u 
pa
ni
c 
an
d 
th
en
 …
P1
6:
 If
 t
he
y 
ha
d 
co
m
e 
qu
ie
tly
 a
nd
 s
ai
d 
w
e’
ll 
gi
ve
 y
ou
 ju
st
 a
 li
tt
le
 
se
da
tiv
e 
be
fo
re
 y
ou
 g
et
 t
he
 m
as
k 
on
 a
nd
 e
xp
la
in
ed
 t
o 
m
e 
w
ha
t 
th
e 
m
as
k 
w
as
 a
bo
ut
. Y
es
 s
om
et
im
es
 y
ou
 d
o 
it,
 w
el
l a
nd
 s
om
et
im
es
 y
ou
 
ha
ve
 t
o,
 I 
kn
ow
 it
 is
 a
bo
ut
 t
he
 b
re
at
hi
ng
, b
ut
 t
he
 fe
ar
 is
 w
or
se
.
H
ea
lth
 p
ro
fe
ss
io
na
l r
ep
or
te
d 
th
at
 a
ll 
pa
tie
nt
s 
di
sp
la
ye
d 
an
xi
et
y,
 a
nd
 t
he
re
 w
er
e 
di
ffe
re
nt
 
su
gg
es
tio
ns
 o
n 
ho
w
 t
o 
he
lp
 t
he
 p
at
ie
nt
 t
o 
co
pe
:
C
: I
 a
ct
ua
lly
 t
hi
nk
 w
e 
ne
ed
 t
o,
 a
t 
th
e 
en
d-
st
ag
e 
C
O
PD
, h
av
e 
so
m
e 
se
da
tiv
e,
 w
hi
ch
 w
e 
do
 n
ot
 h
av
e.
C
: A
s 
th
ey
 s
ay
 t
he
m
se
lv
es
, I
’m
 n
ot
 a
fr
ai
d 
of
 
dy
in
g 
bu
t 
I a
m
 a
fr
ai
d 
of
 t
he
 t
im
e 
be
fo
re
. I
’m
 
af
ra
id
 o
f b
ei
ng
 s
tr
an
gl
ed
, a
s 
th
e 
te
rm
in
al
ly
 
ill
 c
an
ce
r 
pa
tie
nt
s 
sa
ys
, b
ut
 o
ur
 s
ev
er
el
y 
ill
 
C
O
PD
 p
at
ie
nt
 s
ay
s 
th
e 
sa
m
e.
P:
 If
 y
ou
 in
fo
rm
 t
he
m
 (
pa
tie
nt
s)
 in
 t
he
 
be
gi
nn
in
g,
 a
nd
 t
ha
t 
is
 a
ct
ua
lly
, w
hy
 t
he
 n
ur
se
 
is
 t
o 
do
 t
ha
t, 
be
ca
us
e 
th
ey
 h
av
e 
a 
fu
nc
tio
n 
cl
os
e 
to
 t
he
 p
at
ie
nt
, t
he
n 
yo
u 
ca
n 
sp
en
d 
so
m
e 
of
 t
he
 t
im
e 
in
 t
he
 b
eg
in
ni
ng
 a
nd
 t
he
n 
yo
u 
do
n’
t 
ha
ve
 t
o 
sp
en
d 
so
 m
uc
h 
tim
e 
la
te
r.
In
cr
ea
se
d 
fo
cu
s 
on
 b
ei
ng
 c
le
ar
ly
 p
re
se
nt
 t
o 
th
e 
pa
tie
nt
, t
o 
he
lp
 c
op
e 
w
ith
 a
nx
ie
ty
 w
he
n 
in
iti
at
in
g 
tr
ea
tm
en
t 
w
ith
 N
IV
.
Es
ta
bl
is
hm
en
t 
of
 o
ne
 r
oo
m
 a
t 
th
e 
de
pa
rt
m
en
t 
fo
r 
pa
tie
nt
s 
be
in
g 
tr
ea
te
d 
w
ith
 
N
IV
 a
ls
o 
en
ab
le
d 
th
e 
nu
rs
es
 t
o 
be
 a
bl
e 
to
 s
ta
y 
cl
os
er
 t
o 
th
e 
pa
tie
nt
s,
 m
ad
e 
th
em
 
av
ai
la
bl
e.
D
ec
is
io
ns
 r
eg
ar
di
ng
 u
se
 o
f s
ed
at
iv
es
 s
ho
ul
d 
be
 m
ad
e 
du
ri
ng
 t
he
 d
ay
tim
e 
w
ith
 t
he
 
pa
tie
nt
. A
 s
pe
ci
al
iz
ed
 t
ra
in
ed
 s
ta
ff 
sh
ou
ld
 
m
ak
e 
th
es
e 
de
ci
si
on
s.
U
si
ng
 t
he
 w
or
d 
‘lu
ng
 p
al
lia
tiv
e’
 t
o 
fo
cu
s 
on
 
sp
ec
ia
l c
ar
in
g 
ne
ed
s 
fo
r 
pa
tie
nt
s 
in
 t
he
 e
nd
 
st
at
e 
of
 C
O
PD
.
In
fo
rm
at
io
n 
to
 t
he
 p
at
ie
nt
 b
ei
ng
 t
re
at
ed
 
w
ith
 N
IV
 m
us
t 
be
 r
ep
ea
te
d 
of
te
n 
du
e 
to
 
ce
re
br
al
 im
pa
ct
.
CO
PD
 in
 e
ve
ry
da
y 
lif
e
Pa
tie
nt
s 
w
er
e 
te
lli
ng
 a
bo
ut
 h
ow
 t
he
y 
co
pe
d 
w
ith
 C
O
PD
 in
 t
he
ir
 
co
nd
uc
t 
of
 e
ve
ry
da
y 
lif
e.
 L
oo
ki
ng
 a
t 
C
O
PD
 a
s 
a 
ba
si
c 
co
nd
iti
on
:
P4
: I
 d
o 
co
ug
h 
a 
lit
tle
 a
nd
 s
o 
on
, b
ut
 o
th
er
w
is
e 
I d
on
’t 
th
in
k 
I k
in
d 
of
 h
av
e 
pa
rt
ic
ul
ar
ly
 p
oo
r 
br
ea
th
in
g.
 N
o 
I d
on
’t 
th
in
k 
I h
av
e 
ha
d 
th
at
. B
ut
 it
’s
 g
ot
 s
om
et
hi
ng
 t
o 
do
 w
ith
 fi
tn
es
s 
an
d 
st
uf
f s
o,
 n
o,
 I’
m
 
w
al
ki
ng
 w
el
l –
 I 
cu
t 
th
e 
gr
as
s,
 a
nd
 I 
ta
ke
 c
ar
e 
of
 t
he
 g
ar
de
n 
an
d 
th
in
gs
 li
ke
 t
ha
t, 
I d
o 
– 
it 
ju
st
 t
ak
es
 a
 li
tt
le
 lo
ng
er
, b
ut
 t
he
n 
ne
ve
r 
m
in
d.
 B
ut
 it
 d
oe
s,
 it
 t
ak
es
 lo
ng
er
.
P1
6:
 N
o 
I d
on
’t,
 w
he
n 
I h
av
e 
fin
is
he
d 
m
y 
m
or
ni
ng
 t
oi
le
tt
e 
an
d 
I 
ha
ve
 c
au
gh
t 
m
y 
br
ea
th
 a
ga
in
, I
’m
 s
itt
in
g 
he
re
 g
et
tin
g 
m
y 
br
ea
kf
as
t. 
T
he
n 
I d
on
’t 
th
in
k 
at
 t
ha
t 
I’m
 il
l, 
th
en
 I 
fe
el
 g
oo
d 
ag
ai
n.
H
ow
 e
ve
ry
da
y 
lif
e 
w
ith
 C
O
PD
 h
as
 a
n 
im
pa
ct
 o
n 
ho
w
 p
at
ie
nt
s 
ex
pe
ri
en
ce
 t
he
 r
ea
so
ns
 fo
r 
ho
sp
ita
liz
at
io
n.
P1
1:
 W
el
l, 
ye
s,
 a
nd
 w
he
n 
m
y 
C
O
PD
 is
 b
ad
, l
ik
e 
no
w
, i
t 
is
 d
ue
 t
o 
a 
co
ld
, t
ha
t’s
 h
ow
 it
 s
ta
rt
s.
 I 
do
n’
t 
co
ns
id
er
 C
O
PD
 a
s 
a 
hu
ge
 p
ro
bl
em
 
fo
r 
m
e;
 it
 m
ay
 b
e 
a 
m
is
ta
ke
 b
ut
 …
H
ea
lth
 p
ro
fe
ss
io
na
ls
 w
or
ke
d 
w
ith
 t
he
 p
at
ie
nt
s’
 
un
de
rs
ta
nd
in
g 
of
 t
he
ir
 d
is
ea
se
:
C
: B
ec
au
se
 it
’s
 t
he
 p
at
ie
nt
 w
ho
 h
ol
ds
 a
ll 
th
e 
ca
rd
s 
in
 t
he
ir
 h
an
d 
in
 r
el
at
io
n 
to
 w
ha
t 
I w
an
t 
w
ith
 m
y 
lif
e;
 w
ha
t 
th
ey
 h
av
e,
 a
nd
 h
ow
 I 
w
ou
ld
 
lik
e 
to
 le
av
e 
th
is
 li
fe
 h
er
e.
C
: I
t 
w
as
 ju
st
 o
ne
 o
f t
ho
se
 t
hi
ng
s 
sh
e 
(t
he
 
pa
tie
nt
) 
sa
id
, t
ha
t 
th
ey
 a
re
 h
os
pi
ta
liz
ed
, a
nd
 
th
ey
 g
et
 d
ia
gn
os
ed
, a
nd
 t
he
n 
th
ey
 s
ay
, o
h 
m
y 
G
od
, n
ow
 I 
am
 s
ud
de
nl
y 
ill
. N
o,
 y
ou
 h
av
e 
be
en
 il
l f
or
 m
an
y 
ye
ar
s.
C
: I
 t
hi
nk
 it
 is
 t
he
 s
am
e 
as
 w
e 
le
ar
n 
in
 
T
el
eK
O
L 
(S
tu
dy
), 
be
ca
us
e 
th
ey
 d
on
’t 
lo
ok
 
at
 t
he
ir
 d
is
ea
se
 a
s 
so
m
et
hi
ng
 t
he
y 
ca
n 
di
e 
of
, 
ra
th
er
 a
s 
a 
pa
rt
 o
f t
he
ir
 e
ve
ry
da
y 
lif
e,
 it
’s
 a
 
na
tu
ra
l p
ar
t 
of
 t
he
ir
 li
ve
s.
T
he
 n
ur
si
ng
 c
ar
e 
of
 p
at
ie
nt
s 
w
ith
 C
O
PD
 
is
 t
o 
be
 b
as
ed
 o
n 
th
e 
kn
ow
le
dg
e 
th
at
 t
he
y 
w
an
t 
th
e 
tr
ea
tm
en
t 
ev
en
 t
ho
ug
h 
th
ey
 
sh
ow
 r
es
is
ta
nc
e.
 F
oc
us
 o
n 
th
is
 e
sp
ec
ia
lly
 in
 
tr
ai
ni
ng
 n
ew
 s
ta
ff 
in
 t
he
 d
ep
ar
tm
en
t.
In
st
ea
d 
of
 u
si
ng
 t
er
m
in
al
 a
sp
ec
ts
 in
 
tr
ea
tm
en
t, 
a 
w
or
ks
ho
p 
w
ith
 t
he
 h
ea
lth
 
pr
of
es
si
on
al
s 
co
nt
ri
bu
te
d 
to
 n
am
in
g 
as
pe
ct
s 
of
 t
re
at
m
en
t 
in
te
rv
en
tio
ns
 fo
r 
lu
ng
 
pa
lli
at
io
n.
 T
he
 c
ha
ng
e 
of
 w
or
ds
 s
ho
ul
d 
dr
aw
 a
tt
en
tio
n 
to
 a
 fo
cu
s 
on
 p
at
ie
nt
s’
 
ev
er
yd
ay
 li
fe
 w
ith
 a
 d
is
ea
se
 c
on
si
de
re
d 
as
 a
 
ba
si
c 
liv
in
g 
co
nd
iti
on
, a
nd
 t
he
re
fo
re
 r
ar
el
y 
re
al
iz
ed
 b
y 
th
e 
pa
tie
nt
.
N
IV
: n
on
-in
va
si
ve
 v
en
til
at
io
n;
 C
O
PD
: c
hr
on
ic
 o
bs
tr
uc
tiv
e 
pu
lm
on
ar
y 
di
se
as
e.
T
ab
le
 4
. 
(C
on
tin
ue
d)
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condition. It was further exacerbated by the patient’s fear, 
impaired consciousness and feelings of suffocation. Due to 
difficulties in communicating, health professionals inter-
preted the resistance as an expression of not wanting treat-
ment. When the patient was in the end stage of COPD, 
ethical considerations whether to override the resistance or 
to terminate treatment were often-discussed issues. To 
develop management strategies in these situations, there 
was a need to understand patients’ perspectives on treat-
ment with NIV, that is, how patients with COPD under-
stood and related to treatment. When interviewed at home 
after discharge from hospital, some patients did not remem-
ber if they had struggled against the mask. Most patients 
expressed anxiety due to the unfamiliar technology of the 
NIV treatment. They explained that their resistance was 
due to not knowing enough about the treatment, not being 
able to take in and understand what the NIV machine did 
and what it was good for:
I simply did not know what it was. I thought I hadn’t got any 
information about it – also perhaps because I had been too far 
away – I do not know. I probably was. Since I lacked some 
information afterwards, I think. (P7)
Some patients were not aware, until afterwards, that there 
were no possible alternative treatments. Breathing troubles 
were also cited in explaining their resistance. During an 
exacerbation of COPD, their only thought was, to keep 
working on being able to breathe, keeping the airway as free 
as possible. Feeling strangled by the NIV mask caused anxi-
ety. Not being able to think straight, made them focus on 
breathing as a main issue. The patients explained that they 
were often not able to see their conditions in a larger per-
spective in this situation:
I could not even turn myself in bed. They came and pushed it 
down over my head. And it was so terrible. I thought I would 
die. It was – it was as if they intentionally tried to choke you. It 
was as if they just killed you. (P11)
Health professionals expressed two approaches to patient 
resistance: One was to interpret resistance as an expression 
of not wanting NIV treatment. The other was treating to help 
the patient through the acute situation. In this instance, the 
resistance was considered a natural consequence of hypox-
aemia. The co-researcher group all agreed on the importance 
of developing management strategies in NIV practice based 
on patient views and understandings of the treatment. 
Understanding what the patients’ perspective was based on 
when hospitalized became an important issue in further 
interviews. It appeared in the interviews that 15 out of 16 
patients and 4 relatives all expected and wanted to be treated 
with NIV despite displays of resistance. The patients 
explained resistance as a natural reaction to not being able to 
breathe and not having the necessary knowledge and experi-
ence with NIV treatment.
Physical discomfort or relief
In general, all the patients said that NIV was an uncomfort-
able treatment due to the tight mask pushing air in and out, 
demanding the patient to cooperate with the machine. Four 
patients experienced a feeling of claustrophobia due to not 
being able to move from the bed and the tight mask. Some 
patients experienced the mask as a relief as the feeling of 
being choked receded. One patient explained,
You can try to have someone to pull a pillow over your mouth, 
then you can get a sense of it, I think that’s probably the best 
way to … (P6)
Two patients felt NIV treatment as a relief and attached hope 
to the fact that something was being done about their condi-
tion. All relatives had the same experience. The machine was 
new to clinical practice and not well known among patients 
with COPD. The informants expressed difficulties in col-
laborating with the machine due to not knowing the purpose 
of treatment and thinking there might be other possibilities. 
Both patients and health professionals experienced large 
amount of noise from the machine. Combined with the 
breathing problems, it was difficult to communicate and 
understand information, especially at the onset of the treat-
ment. Informants, who had received the treatment more than 
once, said that knowing what it all was about, made it much 
easier to cooperate in the acute situation. This study reveals 
that experience with treatment and the machine eases the 
patients’ anxiety and improves cooperation.
Coping with anxiety
All patients in this study talked about anxiety: anxiety of 
being choked, being alone with new technology, lack of pre-
dictability. They asked themselves; when will you be able to 
have something to drink? When will the staff be back? How 
long will the treatment with the mask go on?
It is an uncertainty that comes from being strapped into 
something that does something for you, which your body does 
not really want. It’s like someone puts something on your head, 
that does something by itself, that your body doesn’t want … 
you are all alone in the world, nobody whispering in your ear: 
‘Try to follow the breathing’. Nobody sits beside you. (P6)
Some of the informants expressed a need for human close-
ness, a feeling of a hand on the arm or just knowing they 
were not alone, that staff had an eye on them, or knowing 
that staff would be back at certain intervals. Knowing that 
you are not alone in coping and cooperating with new tech-
nology helps decrease anxiety:
I did not get any support; they just said ‘so and so’ that’s just not 
me. If they had given me a little sedative. A touch on the hand or 
something, yes, that’s a big help. Then you’re like, oh yeah, they 
have an eye on you … you just have to take it slow, they look 
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after you. I think that was what I missed the most. I was left to 
myself in the machine. It was like I felt like I was all alone in the 
world and then you become afraid of what happens next, what 
happens now. (14K)
Decreased anxiety enabled patients to put more effort in coop-
erating and tolerating the NIV treatment. The person inter-
viewed last had doubts about treatment with NIV, not because 
she did not want treatment, but because she would rather have 
treatment in a respirator. She explained the treatment made her 
feel claustrophobic; she found it difficult to tolerate the mask 
because of the tightness and the anxiety that it produced. To 
cope with the anxiety, she explained that she needed to know 
she was not alone and could contact health professionals regu-
larly. She said that she would have been able to cope with the 
claustrophobia, if she had known from the start when she 
could have a small break to breathe, and water to drink. She 
said all she needed was 5 min every 4 h. The patient also said 
it would help to know from the beginning of the treatment, 
whether it was possible to get anxiolytic medication during the 
night. She needed to know her possibilities before night-time, 
to be able to cope and work together with the machine. If these 
aspects could be part of the treatment, she would want NIV in 
the future. Health professionals expressed that communication 
during treatment was perceived as difficult because of the 
tight fit of the mask and the acute condition. Patient’s fear, 
impaired consciousness and feelings of suffocation also made 
communications difficult.
Future treatment with NIV
Interviews revealed that Chance of survival was voiced by 
15 out of 16 patients (supported by 4 relatives) as a reason to 
accept NIV treatment in future. The initial 12 informants all 
pointed out, in different ways, that they would want treat-
ment with NIV in the future if necessary for a chance to sur-
vive an exacerbation of COPD or pneumonia. Three 
informants who previously had declined NIV treatment dur-
ing hospitalization had changed their opinion about treat-
ment with NIV after being discharged from hospital. All the 
patients, with the exception of number 16, expected the best 
possible treatment. They also expected health professionals 
to be ‘the ones who knew best’ with a knowledge of the opti-
mal and available treatments in the acute situation:
I expect that you know more about this than I do, and that you 
do, whatever you have to do. I have always trusted … what is it 
you call it, the authorities. If you think it might work, then I 
think it is okay. Because for sure, I don’t know as much as you 
do, because you see more of my kind in here. (P4)
All patients stated that they, in connection with their hospitali-
zation, expected to be treated if there was a hope of survival. 
Through the interviews, it was made clear the informant’s 
conduct of everyday life with COPD had a great impact on, 
what expectations the informant had towards hospitalization 
due to breathing problems. Patients’ interviews showed they 
considered living with COPD as a basic condition more than a 
disease. The event of an acute exacerbation of COPD causing 
a need for hospitalization was considered by the informants as 
a result of a cold or pneumonia, a new situation that was well 
known and normally could be treated. Patients’ interviews 
revealed that they relied on health professionals being well-
educated and able to take the responsibility of starting treat-
ment with NIV, even in the face of patient resistance. Contrary 
to this, health professionals understood hospitalization and 
NIV treatment to patients with COPD as a development or 
worsening of COPD. They therefore understood the resistance 
against treatment as a way of showing that patients did not 
want the treatment due to the severe COPD.
Discussion
Strengths and weaknesses of the study
A strength of the study was to investigate drawing on user 
perspectives. It emerged to play a crucial role in developing 
new management strategies to improve the quality in treat-
ment and care to patients with COPD. Another strength was 
the similarity in the patient’s perspectives on treatment. In all, 
15 out of 16 patients wanted treatment with NIV in the future 
despite resistance in the acute situation. Interviews also 
revealed that chance of survival was voiced by 15 out of 16 
patients (supported by 4 relatives) as a reason to accept NIV 
treatment in future. The emerging patients’ perspectives and 
management strategies resulted from the involvement of the 
co-researchers and could be integrated into daily routines and 
also further reflected upon during the research process. The 
joint analysis of the clinical practice with NIV treatment on 
the ward and the shared data analysis involving both patients 
and health professionals’ perspectives ensured consistency of 
results. The co-researcher group confirmed the main themes 
identified by the researcher in the semi-structured interviews 
of the patients and their relatives.
Weakness of the study: Given the health needs of COPD 
patients, it was impossible to involve them more actively in 
the study. This lack of patient representation (either in the co-
researcher group or in a reference group) could be seen as a 
weakness. To work with a co-researcher group with members 
from interdisciplinary health professionals required the depart-
ment to allow time for the meetings. It could only be done 
with support from the department management and commit-
ment from all staff members. This is a potential weakness of 
the methodological approach. A potential weakness is also the 
lack of time from patients’ hospitalization and the semi-struc-
tured interview. This time break can cause memory bias. Still 
this study looks further into the attitude towards receiving 
NIV considering how they relates to, and live their lives with 
a chronical illness COPD, where hospitalization due to acute 
exacerbation of COPD is a progress of their illness. It was 
therefore important to interview the patients after some recov-
ering from the acute exacerbation of COPD.
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Summary of main findings
Four main themes emerged through the analysis: understand-
ing resistance towards treatment, physical discomfort or 
relief, coping with anxiety and future treatment with NIV. 
The patients explained their resistance against NIV during 
treatment as being due to anxiety, difficulties in coping with 
NIV and blurred consciousness. Patients and health profes-
sionals had different approaches towards hospitalization and 
treatment. This was clarified through joint analyses in the 
co-researcher group. Patients considered the hospitalization 
and the treatment as a new illness and the COPD as a basic 
condition of their conduct of everyday life. Health profes-
sionals considered a patient with severe COPD being hospi-
talized due to breathing troubles as a continuing progress of 
COPD. The discrepancies in the approaches towards hospi-
talization were the main reason for complications in daily 
management. New management strategies were developed 
based on these perspectives.
The patients in this study expected health professionals to 
make enlightened decisions in the acute situation of begin-
ning treatment with NIV. At this point, patients’ conscious-
ness was often blurred due to anxiety, increased CO2 levels 
in the blood and fatigue. Because patients conducted their 
everyday lives with COPD as a basic condition, the patients 
did not consider COPD as the reason for hospitalization. 
Rather, they looked at it as a new event such as a cold or 
pneumonia, which was usually treatable. This study showed 
that the conduct of everyday life has a great impact on the 
expectations patients with COPD have to hospitalization due 
to breathing troubles. Patients’ conduct of everyday life with 
COPD as a basic condition rather than an illness and how it 
influenced their expectations to hospitalizations was also 
confirmed in the study by Pinnock et al.15 Pinnock et al. 
investigated patients’ attitudes towards living with COPD. 
COPD was considered as a basic condition in their lives, 
based on the slow development of the disease, without a start 
date. The study results by Pinnock et al.15 were included in 
analyses of patients’ perspective and supported the findings. 
Our results showed that focusing on user perspectives in 
health care practices consisting of NIV treatment in a hospi-
tal ward, and defining users as patients, relatives and health 
professionals, contributed to new knowledge that was useful 
in developing management strategies for this treatment. It 
was therefore important to use the knowledge of these 
patients’ perspectives on treatment in developing manage-
ment strategies for NIV. This practice enabled exploration 
and development of new clinical strategies based on patient 
and health care professional’s perspectives on treating 
patients with COPD with NIV.
Results in relation to other studies
The results from this study are comparable to a study by 
Pinnock et al.15 on how patients with COPD live their every-
day lives, in and across different contexts, experiencing 
COPD as a condition of life rather than as illness: ‘Not so 
much an illness, more a way of life’.15 This study showed that 
a lack of knowledge of patient perspectives on treatment was 
problematic. It could cause major problems in everyday clini-
cal practice in a hospital ward, when starting up treatment 
with NIV to patients in the end stage of the disease. The study 
by Gore et al.16 comparing how patients with lung cancer and 
COPD are treated shows that these patients’ needs are much 
alike, because of a communality of symptoms. However, care 
for patients with COPD is deficient because of the invisibility 
of the disease and the impact on how patients live their every-
day lives. Problems due to the NIV mask were investigated in 
the study by Sørensen et al.18 and Torheim and Gjengedal.11 
The studies reported that patients describe anxiety as a major 
aspect in coping with NIV treatment.
The patients were interviewed up to 2 years after treat-
ment which is a rather long duration. It may not necessarily 
reflect the absolute experience during the treatment itself due 
Table 5. What this study adds.
What was known What this study adds
There is solid evidence for using NIV as 
treatment for patients with COPD in 
exacerbation.
Health professionals experience ethical challenges when starting treatment with 
patients who resist. This is particularly true of end-stage patients.
Special skills are important for nursing 
patients in NIV treatment. This is due to 
patient difficulties in connection with the 
NIV machine.
Special nursing skills are required when starting NIV treatment with COPD patients. 
Skills comprising technical knowledge, helping patients cope with anxiety, physical 
presence, predictability in the care process, information about the NIV machine and 
help to learn how to cooperate with it.
Patient often shows resistance when 
starting up NIV treatment.
Patients explain resistance as an automatic response to experiencing breathing 
troubles and being affected by the emergency. It feels unnatural to have something 
plastic fitted tightly over nose and mouth. In a patient’s conduct of everyday life, 
COPD is more a condition of life than an illness. This means that hospitalization 
is experienced as a new event: A cold, the flu or pneumonia which can usually be 
treated. Therefore, they expect treatment when hospitalized and they expect health 
professionals to do whatever they can, in the hope of getting through the acute stage.
NIV: non-invasive ventilation; COPD: chronic obstructive pulmonary disease.
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to memory relapse. This study looks further into the attitude 
towards receiving NIV considering how they relates to, and 
live their lives with a chronical illness COPD, where hospi-
talization due to acute exacerbation of COPD is a progress of 
their illness. The focus was to interview the patients after 
some recovering from the acute exacerbation of COPD. All 
the informant could in detail describe and relate to their hos-
pitalization and treatment with NIV.
This study revealed differences in patients’ and health care 
professionals’ perspectives on treatment and their expecta-
tions concerning the hospitalization (Table 5). It highlighted 
the importance of exploring and drawing on patient’s perspec-
tives in other areas of treatments and care to patients with 
COPD.
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